Cambridge-based flexible organic electronics company specializing in organic transistors, large-area sensors, and graphene device integration for pilot-scale manufacturing.
FlexEnable develops flexible organic electronics technology, specializing in organic thin-film transistors (OTFTs) and large-area flexible displays and sensors. Based in Cambridge, they provide the manufacturing processes and materials expertise to turn rigid electronic components — displays, X-ray imagers, biosensors — into flexible, conformable devices. Their work spans from organic semiconductor modeling to pilot-scale production of flexible OLED lighting, organic X-ray detectors, and printable bio-electronic sensor arrays for clinical diagnostics.
Core capability demonstrated across PI-SCALE (pilot-scale OLED), ATLASS (printed transistors), EXTMOS (organic semiconductor modeling), LORIX (organic X-ray imagers), FLOIM (flexible optical moulding), and SiMBiT (printable organic sensors).
Continuous involvement in the Graphene Flagship across all three core phases (GrapheneCore1, Core2, Core3) plus the 2D Experimental Pilot Line (2D-EPL).
LORIX developed large organic X-ray imagers (largest single EC grant at EUR 971K), SiMBiT built bio-electronic sensor arrays, and ATLASS created printed transistors for smart surfaces.
FLOIM focused on flexible optical injection moulding for LED and optoelectronic devices; PHENOMENON addressed laser-manufactured 3D nanostructured optics.
SiMBiT (2019-2022) applied their organic transistor expertise to single-molecule bio-electronic sensing arrays for clinical diagnostics, signaling a move into health applications.
In 2014-2018, FlexEnable focused on establishing flexible electronics as a viable manufacturing platform — working on OLED lighting, flexible displays, automotive applications, and organic semiconductor modeling (PI-SCALE, ATLASS, EXTMOS). From 2018 onward, their focus shifted toward applying these capabilities to specific high-value domains: graphene-based devices intensified (three consecutive Flagship phases), biomedical sensing emerged (SiMBiT), and advanced optics manufacturing appeared (FLOIM, PHENOMENON). The trajectory shows a company moving from "can we make flexible electronics work?" to "where do flexible electronics create the most value?"
FlexEnable is pivoting from general flexible electronics R&D toward application-specific platforms in health diagnostics and graphene-based pilot production, making them a strong partner for projects needing flexible sensor fabrication at scale.
FlexEnable operates exclusively as a participant — across all 13 projects they never coordinated, indicating they position themselves as a specialist technology contributor rather than a project leader. With 326 unique consortium partners across 24 countries, they are deeply embedded in Europe's advanced materials and electronics research networks. Their consistent presence in mega-consortia like the Graphene Flagship alongside smaller focused projects (LORIX, SiMBiT) suggests they are a trusted, reliable partner comfortable in both large and mid-sized collaborations.
FlexEnable has built one of the broadest collaboration networks among UK-based electronics companies in H2020, with 326 unique partners spanning 24 countries — largely driven by their sustained participation in the Graphene Flagship's massive consortia. Their network is heavily European but exceptionally diverse geographically.
FlexEnable occupies a rare niche: they are one of very few companies worldwide that can take organic transistor and flexible electronics designs from lab concept to pilot-line manufacturing. Their decade-long track record in both the Graphene Flagship and multiple focused electronics projects gives them deep connections across Europe's advanced materials ecosystem. For consortium builders, they bring not just flexible electronics fabrication capability but also a proven ability to integrate into complex multi-partner projects as a dependable technology provider.
